Stockholders' Equity |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| Stockholders' Equity | 10. Stockholders' Equity On November 3, 2025, our board of directors authorized a new share repurchase program under which we may repurchase up to $125.0 million of our outstanding shares of common stock. For the three months ended June 30, 2026, we repurchased 1,403,247 shares in the open market at an average price of $22.36 per share for a total amount of approximately $31.4 million. For the six months ended June 30, 2026, we repurchased 2,374,313 shares in the open market at an average price of $21.83 per share for a total amount of approximately $51.8 million. From program inception through June 30, 2026, we have repurchased Innoviva common stock in the open market for a total price of approximately $56.4 million. Subsequent to June 30, 2026, and through July 31, 2026, we have repurchased 453,798 shares in the open market for a total of approximately $10.0 million. All repurchased shares were retired. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|